$ORGN
Origin Materials, Inc. Stock $orgn

$orgn Overview Financials Valuation SEC Filings Company Website

2023 Q1 Form 10-K Financial Statement

#000180245723000018 Filed on February 23, 2023

Income Statement

Concept	2023 Q1	2022 Q4	2022
Revenue	$1.700M	$0.00	$0.00
YoY Change
Cost Of Revenue	$960.0K
YoY Change
Gross Profit	$740.0K
YoY Change
Gross Profit Margin	43.53%
Selling, General & Admin	$7.656M	$7.326M	$24.10M
YoY Change	50.98%	80.67%	39.56%
% of Gross Profit	1034.59%
Research & Development	$5.075M	$5.424M	$14.14M
YoY Change	117.16%	54.13%	54.99%
% of Gross Profit	685.81%
Depreciation & Amortization	$288.0K	$223.0K	$711.0K
YoY Change	94.59%	22.53%	30.7%
% of Gross Profit	38.92%
Operating Expenses	$13.02M	$12.97M	$38.95M
YoY Change	72.3%	67.29%	44.61%
Operating Profit	-$12.28M		-$38.95M
YoY Change	62.45%
Interest Expense	$2.974M	$580.0K	$0.00
YoY Change		-61.69%	-100.0%
% of Operating Profit
Other Income/Expense, Net	$22.04M	$28.39M	$117.5M
YoY Change	47.93%	147.31%	70.26%
Pretax Income	$9.769M	$15.99M	$78.57M
YoY Change	32.98%	205.38%	86.66%
Income Tax	$0.00		$3.000K
% Of Pretax Income	0.0%		0.0%
Net Earnings	$9.769M	$15.99M	$78.57M
YoY Change	32.98%	205.38%	86.67%
Net Earnings / Revenue	574.65%
Basic Earnings Per Share	$0.07		$0.57
Diluted Earnings Per Share	$0.07	$0.11	$0.55
COMMON SHARES
Basic Shares Outstanding	143.1M shares	142.7M shares	137.6M shares
Diluted Shares Outstanding	142.5M shares		142.1M shares

Balance Sheet

Concept	2023 Q1	2022 Q4	2022
SHORT-TERM ASSETS
Cash & Short-Term Investments	$263.9M	$323.3M	$323.3M
YoY Change	-38.22%	-27.2%	-27.2%
Cash & Equivalents	$86.95M	$107.9M
Short-Term Investments	$177.0M	$215.5M	$215.5M
Other Short-Term Assets	$4.858M	$3.831M	$3.831M
YoY Change	48.93%	-14.22%	-14.22%
Inventory	$328.0K	$0.00
Prepaid Expenses
Receivables	$1.479M	$0.00
Other Receivables	$6.444M	$4.346M
Total Short-Term Assets	$277.0M	$331.5M	$331.5M
YoY Change	-36.06%	-26.53%	-26.53%
LONG-TERM ASSETS
Property, Plant & Equipment	$190.7M	$154.2M	$157.0M
YoY Change	175.02%	169.62%	166.19%
Goodwill
YoY Change
Intangibles	$150.0K	$160.0K
YoY Change	-27.18%	-25.58%
Long-Term Investments
YoY Change
Other Assets	$12.99M	$5.079M	$5.079M
YoY Change	13575.79%	8091.94%	8091.94%
Total Long-Term Assets	$206.4M	$162.2M	$162.2M
YoY Change	185.37%	173.78%	173.78%
TOTAL ASSETS
Total Short-Term Assets	$277.0M	$331.5M	$331.5M
Total Long-Term Assets	$206.4M	$162.2M	$162.2M
Total Assets	$483.5M	$493.7M	$493.7M
YoY Change	-4.38%	-3.28%	-3.28%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$7.922M	$10.38M	$10.38M
YoY Change	156.54%	323.66%	323.66%
Accrued Expenses	$5.686M	$8.414M	$9.033M
YoY Change	130.39%	764.75%	620.91%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$15.02M	$19.81M	$19.81M
YoY Change	114.48%	373.18%	373.18%
LONG-TERM LIABILITIES
Long-Term Debt	$5.189M	$5.847M	$5.847M
YoY Change	0.0%	12.68%	12.68%
Other Long-Term Liabilities	$8.829M	$2.902M	$91.14M
YoY Change	204.45%	-1.49%	-53.86%
Total Long-Term Liabilities	$8.829M	$2.902M	$96.98M
YoY Change	204.45%	-1.49%	-52.16%
TOTAL LIABILITIES
Total Short-Term Liabilities	$15.02M	$19.81M	$19.81M
Total Long-Term Liabilities	$8.829M	$2.902M	$96.98M
Total Liabilities	$92.33M	$116.8M	$116.8M
YoY Change	-53.19%	-43.55%	-43.55%
SHAREHOLDERS EQUITY
Retained Earnings	$31.54M	$21.77M
YoY Change	-163.78%	-138.33%
Common Stock	$14.00K	$14.00K
YoY Change	-12.5%	-12.5%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$391.1M	$376.9M	$376.9M
YoY Change
Total Liabilities & Shareholders Equity	$483.5M	$493.7M	$493.7M
YoY Change	-4.38%	-3.28%	-3.28%

Cashflow Statement

Concept	2023 Q1	2022 Q4	2022
OPERATING ACTIVITIES
Net Income	$9.769M	$15.99M	$78.57M
YoY Change	32.98%	205.38%	86.67%
Depreciation, Depletion And Amortization	$288.0K	$223.0K	$711.0K
YoY Change	94.59%	22.53%	30.7%
Cash From Operating Activities	-$19.07M	-$16.63M	-$26.09M
YoY Change	1378.06%	158.75%	18.37%
INVESTING ACTIVITIES
Capital Expenditures	$40.96M	$25.98M	$83.69M
YoY Change	294.63%	-453.15%	582.19%
Acquisitions
YoY Change
Other Investing Activities	$39.13M	$44.84M	$172.8M
YoY Change	66.57%	-111.23%	-143.29%
Cash From Investing Activities	-$1.830M	$18.86M	$88.85M
YoY Change	-113.98%	-104.64%	-121.58%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	$33.00K	877.0K	$1.248M
YoY Change	-2.94%	220.07%	-99.74%
NET CHANGE
Cash From Operating Activities	-$19.07M	-16.63M	-$26.09M
Cash From Investing Activities	-$1.830M	18.86M	$88.85M
Cash From Financing Activities	$33.00K	877.0K	$1.248M
Net Change In Cash	-$20.90M	3.111M	$61.22M
YoY Change	-284.93%	-100.75%	35.29%
FREE CASH FLOW
Cash From Operating Activities	-$19.07M	-$16.63M	-$26.09M
Capital Expenditures	$40.96M	$25.98M	$83.69M
Free Cash Flow	-$60.03M	-$42.61M	-$109.8M
YoY Change	414.4%	-4686.44%	219.96%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022	dei	Amendment Flag AmendmentFlag	false
CY2022	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
CY2022	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2022	dei	Entity Central Index Key EntityCentralIndexKey	0001802457
CY2022	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1	segment
CY2022Q4	us-gaap	Derivative Liability Statement Of Financial Position Extensible Enumeration DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumeration	http://fasb.org/us-gaap/2022#DerivativeLiabilitiesCurrent
CY2021Q4	us-gaap	Derivative Asset Statement Of Financial Position Extensible Enumeration DerivativeAssetStatementOfFinancialPositionExtensibleEnumeration	http://fasb.org/us-gaap/2022#DerivativeAssetsCurrent
CY2022	dei	Document Type DocumentType	10-K
CY2022	dei	Document Annual Report DocumentAnnualReport	true
CY2022	dei	Document Period End Date DocumentPeriodEndDate	2022-12-31
CY2022	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2022	dei	Document Transition Report DocumentTransitionReport	false
CY2022	dei	Entity File Number EntityFileNumber	001-39378
CY2022	dei	Entity Registrant Name EntityRegistrantName	ORIGIN MATERIALS, INC.
CY2022	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2022	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	87-1388928
CY2022	dei	Entity Address Address Line1 EntityAddressAddressLine1	930 Riverside Parkway
CY2022	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 10
CY2022	dei	Entity Address City Or Town EntityAddressCityOrTown	West Sacramento,
CY2022	dei	Entity Address State Or Province EntityAddressStateOrProvince	CA
CY2022	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	95605
CY2022	dei	City Area Code CityAreaCode	916
CY2022	dei	Local Phone Number LocalPhoneNumber	231-9329
CY2022	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2022	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2022	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2022	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2022	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2022	dei	Entity Small Business EntitySmallBusiness	false
CY2022	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2022	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	true
CY2022	dei	Entity Shell Company EntityShellCompany	false
CY2022Q2	dei	Entity Public Float EntityPublicFloat	630100000	usd
CY2023Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	143099850	shares
CY2022	dei	Auditor Firm AuditorFirmId	248
CY2022	dei	Auditor Name AuditorName	GRANT THORNTON LLP
CY2022	dei	Auditor Location AuditorLocation	San Jose, California
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	107858000	usd
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	46637000	usd
CY2022Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	490000	usd
CY2021Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	490000	usd
CY2022Q4	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	215464000	usd
CY2021Q4	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	397458000	usd
CY2022Q4	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	4346000	usd
CY2021Q4	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	2612000	usd
CY2022Q4	us-gaap	Derivative Assets Current DerivativeAssetsCurrent	0	usd
CY2021Q4	us-gaap	Derivative Assets Current DerivativeAssetsCurrent	202000	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	3341000	usd
CY2021Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	3774000	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	331499000	usd
CY2021Q4	us-gaap	Assets Current AssetsCurrent	451173000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	154183000	usd
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	57185000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	2779000	usd
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1782000	usd
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	160000	usd
CY2021Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	215000	usd
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	5079000	usd
CY2021Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	62000	usd
CY2022Q4	us-gaap	Assets Assets	493700000	usd
CY2021Q4	us-gaap	Assets Assets	510417000	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	10384000	usd
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	2451000	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	8414000	usd
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	973000	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	619000	usd
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	280000	usd
CY2022Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	51000	usd
CY2021Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	380000	usd
CY2022Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	344000	usd
CY2021Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	103000	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	19812000	usd
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	4187000	usd
CY2022Q4	us-gaap	Unsecured Long Term Debt UnsecuredLongTermDebt	42533000	usd
CY2021Q4	us-gaap	Unsecured Long Term Debt UnsecuredLongTermDebt	127757000	usd
CY2022Q4	orgn	Research And Development Program Liability Noncurrent ResearchAndDevelopmentProgramLiabilityNoncurrent	7185000	usd
CY2021Q4	orgn	Research And Development Program Liability Noncurrent ResearchAndDevelopmentProgramLiabilityNoncurrent	6762000	usd
CY2022Q4	orgn	Assumed Common Stock Warrants Liability Noncurrent AssumedCommonStockWarrantsLiabilityNoncurrent	30872000	usd
CY2021Q4	orgn	Assumed Common Stock Warrants Liability Noncurrent AssumedCommonStockWarrantsLiabilityNoncurrent	52860000	usd
CY2022Q4	orgn	Stockholder Note Liabilities Noncurrent StockholderNoteLiabilitiesNoncurrent	5847000	usd
CY2021Q4	orgn	Stockholder Note Liabilities Noncurrent StockholderNoteLiabilitiesNoncurrent	5189000	usd
CY2022Q4	us-gaap	Due To Related Parties Noncurrent DueToRelatedPartiesNoncurrent	5395000	usd
CY2021Q4	us-gaap	Due To Related Parties Noncurrent DueToRelatedPartiesNoncurrent	5720000	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	2249000	usd
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1486000	usd
CY2022Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	2902000	usd
CY2021Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	2946000	usd
CY2022Q4	us-gaap	Liabilities Liabilities	116795000	usd
CY2021Q4	us-gaap	Liabilities Liabilities	206907000	usd
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2021Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2021Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2021Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2021Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2021Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2021Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	1000000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	1000000000	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	143034225	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	143034225	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	141301569	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	141301569	shares
CY2022Q4	orgn	Sponsor Vesting Shares Outstanding SponsorVestingSharesOutstanding	4500000	shares
CY2021Q4	orgn	Sponsor Vesting Shares Outstanding SponsorVestingSharesOutstanding	4500000	shares
CY2022Q4	orgn	Sponsor Vesting Shares Issued SponsorVestingSharesIssued	4500000	shares
CY2021Q4	orgn	Sponsor Vesting Shares Issued SponsorVestingSharesIssued	4500000	shares
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	14000	usd
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	16000	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	371072000	usd
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	361542000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	21772000	usd
CY2021	orgn	Change In Fair Value Of Earnout Liability ChangeInFairValueOfEarnoutLiability	75488000	usd
CY2020	orgn	Change In Fair Value Of Earnout Liability ChangeInFairValueOfEarnoutLiability	0	usd
CY2022	us-gaap	Other Nonrecurring Gain OtherNonrecurringGain	1709000	usd
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-56797000	usd
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-15953000	usd
CY2021Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-1251000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	376905000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	303510000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	493700000	usd
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	510417000	usd
CY2022	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	14141000	usd
CY2021	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	9124000	usd
CY2020	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	4138000	usd
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	24095000	usd
CY2021	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	17265000	usd
CY2020	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	6563000	usd
CY2022	us-gaap	Depreciation And Amortization DepreciationAndAmortization	711000	usd
CY2021	us-gaap	Depreciation And Amortization DepreciationAndAmortization	544000	usd
CY2020	us-gaap	Depreciation And Amortization DepreciationAndAmortization	479000	usd
CY2022	us-gaap	Operating Expenses OperatingExpenses	38947000	usd
CY2021	us-gaap	Operating Expenses OperatingExpenses	26933000	usd
CY2020	us-gaap	Operating Expenses OperatingExpenses	11180000	usd
CY2022	us-gaap	Investment Income Interest InvestmentIncomeInterest	8825000	usd
CY2021	us-gaap	Investment Income Interest InvestmentIncomeInterest	1413000	usd
CY2020	us-gaap	Investment Income Interest InvestmentIncomeInterest	0	usd
CY2022	us-gaap	Interest Expense InterestExpense	0	usd
CY2021	us-gaap	Interest Expense InterestExpense	2838000	usd
CY2020	us-gaap	Interest Expense InterestExpense	341000	usd
CY2022	orgn	Change In Fair Value Of Derivatives ChangeInFairValueOfDerivatives	443000	usd
CY2021	orgn	Change In Fair Value Of Derivatives ChangeInFairValueOfDerivatives	1326000	usd
CY2020	orgn	Change In Fair Value Of Derivatives ChangeInFairValueOfDerivatives	1088000	usd
CY2022	orgn	Change In Fair Value Of Warrant Liability ChangeInFairValueOfWarrantLiability	-21988000	usd
CY2021	orgn	Change In Fair Value Of Warrant Liability ChangeInFairValueOfWarrantLiability	4525000	usd
CY2020	orgn	Change In Fair Value Of Warrant Liability ChangeInFairValueOfWarrantLiability	18498000	usd
CY2022	orgn	Change In Fair Value Of Earnout Liability ChangeInFairValueOfEarnoutLiability	85437000	usd
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-30302000	usd
CY2020	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	794000	usd
CY2021	us-gaap	Other Nonrecurring Gain OtherNonrecurringGain	811000	usd
CY2020	us-gaap	Other Nonrecurring Gain OtherNonrecurringGain	805000	usd
CY2022	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	117516000	usd
CY2021	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	69023000	usd
CY2020	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-19122000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	78569000	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	42090000	usd
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-30302000	usd
CY2022	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-8014000	usd
CY2021	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-1712000	usd
CY2020	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	0	usd
CY2022	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-6688000	usd
CY2021	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	77000	usd
CY2020	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	794000	usd
CY2022	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	63867000	usd
CY2021	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	40455000	usd
CY2020	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-29508000	usd
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.57
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.42
CY2020	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.48
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.55
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.40
CY2020	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.48
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	137563877	shares
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	101221781	shares
CY2020	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	62544933	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	142146767	shares
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	106237754	shares
CY2020	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	62544933	shares
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	27999000	usd
CY2020	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	2000	usd
CY2020	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1630000	usd
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	123000	usd
CY2021	orgn	Reclassification Of Stockholders Convertible Notes Payable ReclassificationOfStockholdersConvertibleNotesPayable	20491000	usd
CY2021	orgn	Reclassification Of Redeemable Convertible Preferred Stock Warrant Liability ReclassificationOfRedeemableConvertiblePreferredStockWarrantLiability	54274000	usd
CY2021	orgn	Equity Issuance Costs EquityIssuanceCosts	37000000	usd
CY2021	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	385405000	usd
CY2021	orgn	Reclassification Of Equity To Liability Related To Earn Out Provisions Of Business Combination ReclassificationOfEquityToLiabilityRelatedToEarnOutProvisionsOfBusinessCombination	-203082000	usd
CY2021	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	77000	usd
CY2021	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	5767000	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	42090000	usd
CY2021	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-1635000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	303510000	usd
CY2022	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	401000	usd
CY2022	orgn	Stock Issued During Period Value Common Stock Award Vested StockIssuedDuringPeriodValueCommonStockAwardVested	-2000	usd
CY2022	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	9129000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	78569000	usd
CY2022	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-14702000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	376905000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	78569000	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	42090000	usd
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-30302000	usd
CY2022	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	711000	usd
CY2021	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	544000	usd
CY2020	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	479000	usd
CY2022	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	582000	usd
CY2021	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	280000	usd
CY2020	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	0	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	7235000	usd
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	5767000	usd
CY2020	us-gaap	Share Based Compensation ShareBasedCompensation	1630000	usd
CY2022	orgn	Amortization Of Deb Issuance Costs AmortizationOfDebIssuanceCosts	0	usd
CY2021	orgn	Amortization Of Deb Issuance Costs AmortizationOfDebIssuanceCosts	14000	usd
CY2020	orgn	Amortization Of Deb Issuance Costs AmortizationOfDebIssuanceCosts	90000	usd
CY2022	orgn	Accretion Of Debt Discount AccretionOfDebtDiscount	0	usd
CY2021	orgn	Accretion Of Debt Discount AccretionOfDebtDiscount	2211000	usd
CY2020	orgn	Accretion Of Debt Discount AccretionOfDebtDiscount	101000	usd
CY2022	orgn	Change In Fair Value Of Derivatives ChangeInFairValueOfDerivatives	443000	usd
CY2021	orgn	Change In Fair Value Of Derivatives ChangeInFairValueOfDerivatives	1326000	usd
CY2020	orgn	Change In Fair Value Of Derivatives ChangeInFairValueOfDerivatives	1088000	usd
CY2022	orgn	Change In Fair Value Of Common Stock Warrants Liability ChangeInFairValueOfCommonStockWarrantsLiability	-21988000	usd
CY2021	orgn	Change In Fair Value Of Common Stock Warrants Liability ChangeInFairValueOfCommonStockWarrantsLiability	-30510000	usd
CY2020	orgn	Change In Fair Value Of Common Stock Warrants Liability ChangeInFairValueOfCommonStockWarrantsLiability	0	usd
CY2022	orgn	Change In Fair Value Of Warrants Liability ChangeInFairValueOfWarrantsLiability	0	usd
CY2021	orgn	Change In Fair Value Of Warrants Liability ChangeInFairValueOfWarrantsLiability	35035000	usd
CY2020	orgn	Change In Fair Value Of Warrants Liability ChangeInFairValueOfWarrantsLiability	18498000	usd
CY2022	orgn	Change In Fair Value Of Earnout Liability ChangeInFairValueOfEarnoutLiability	85437000	usd
CY2021	orgn	Change In Fair Value Of Earnout Liability ChangeInFairValueOfEarnoutLiability	75488000	usd
CY2020	orgn	Change In Fair Value Of Earnout Liability ChangeInFairValueOfEarnoutLiability	0	usd
CY2022	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	1734000	usd
CY2021	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	2563000	usd
CY2020	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	-1007000	usd
CY2022	orgn	Increase Decrease In Grants Receivable IncreaseDecreaseInGrantsReceivable	0	usd
CY2021	orgn	Increase Decrease In Grants Receivable IncreaseDecreaseInGrantsReceivable	0	usd
CY2020	orgn	Increase Decrease In Grants Receivable IncreaseDecreaseInGrantsReceivable	-87000	usd
CY2022	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-432000	usd
CY2021	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	3652000	usd
CY2020	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-53000	usd
CY2022	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	5017000	usd
CY2021	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	0	usd
CY2020	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	0	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	26000	usd
CY2021	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-395000	usd
CY2020	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	1203000	usd
CY2022	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	485000	usd
CY2021	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	3010000	usd
CY2020	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	349000	usd
CY2022	us-gaap	Operating Lease Payments OperatingLeasePayments	572000	usd
CY2021	us-gaap	Operating Lease Payments OperatingLeasePayments	295000	usd
CY2020	us-gaap	Operating Lease Payments OperatingLeasePayments	0	usd
CY2022	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	-329000	usd
CY2021	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	380000	usd
CY2020	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	0	usd
CY2022	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	502000	usd
CY2021	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	203000	usd
CY2020	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	256000	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-26092000	usd
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-22043000	usd
CY2020	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-5461000	usd
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	83691000	usd
CY2021	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	12268000	usd
CY2020	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1786000	usd
CY2022	us-gaap	Payments To Acquire Available For Sale Securities Debt PaymentsToAcquireAvailableForSaleSecuritiesDebt	3823407000	usd
CY2021	us-gaap	Payments To Acquire Available For Sale Securities Debt PaymentsToAcquireAvailableForSaleSecuritiesDebt	2448316000	usd
CY2020	us-gaap	Payments To Acquire Available For Sale Securities Debt PaymentsToAcquireAvailableForSaleSecuritiesDebt	0	usd
CY2022	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	3815859000	usd
CY2021	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	2024089000	usd
CY2020	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	0	usd
CY2022	us-gaap	Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities	180331000	usd
CY2021	us-gaap	Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities	25058000	usd
CY2020	us-gaap	Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities	0	usd
CY2022	orgn	Payments Of Interest Capitalized To Property Plant And Equipment PaymentsOfInterestCapitalizedToPropertyPlantAndEquipment	245000	usd
CY2021	orgn	Payments Of Interest Capitalized To Property Plant And Equipment PaymentsOfInterestCapitalizedToPropertyPlantAndEquipment	201000	usd
CY2020	orgn	Payments Of Interest Capitalized To Property Plant And Equipment PaymentsOfInterestCapitalizedToPropertyPlantAndEquipment	268000	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	88847000	usd
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-411638000	usd
CY2020	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-2054000	usd
CY2022	us-gaap	Proceeds From Debt Net Of Issuance Costs ProceedsFromDebtNetOfIssuanceCosts	0	usd
CY2021	us-gaap	Proceeds From Debt Net Of Issuance Costs ProceedsFromDebtNetOfIssuanceCosts	11707000	usd
CY2020	us-gaap	Proceeds From Debt Net Of Issuance Costs ProceedsFromDebtNetOfIssuanceCosts	3166000	usd
CY2022	us-gaap	Repayments Of Short Term Debt RepaymentsOfShortTermDebt	0	usd
CY2021	us-gaap	Repayments Of Short Term Debt RepaymentsOfShortTermDebt	906000	usd
CY2020	us-gaap	Repayments Of Short Term Debt RepaymentsOfShortTermDebt	0	usd
CY2022	orgn	Proceeds From Research And Development Program ProceedsFromResearchAndDevelopmentProgram	849000	usd
CY2021	orgn	Proceeds From Research And Development Program ProceedsFromResearchAndDevelopmentProgram	543000	usd
CY2020	orgn	Proceeds From Research And Development Program ProceedsFromResearchAndDevelopmentProgram	2662000	usd
CY2022	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	399000	usd
CY2021	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	74000	usd
CY2020	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	1000	usd
CY2022	orgn	Proceeds For Business Combination Net Of Issuance Costs Paid ProceedsForBusinessCombinationNetOfIssuanceCostsPaid	0	usd
CY2021	orgn	Proceeds For Business Combination Net Of Issuance Costs Paid ProceedsForBusinessCombinationNetOfIssuanceCostsPaid	467530000	usd
CY2020	orgn	Proceeds For Business Combination Net Of Issuance Costs Paid ProceedsForBusinessCombinationNetOfIssuanceCostsPaid	0	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1248000	usd
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	478948000	usd
CY2020	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	5829000	usd
CY2022	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-2782000	usd
CY2021	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-14000	usd
CY2020	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-52000	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	61221000	usd
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	45253000	usd
CY2020	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-1738000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	47127000	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1874000	usd
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	3612000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	108348000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	47127000	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1874000	usd
CY2022	orgn	Conversion Of Stockholder Convertible Notes Payable To Common Stock ConversionOfStockholderConvertibleNotesPayableToCommonStock	0	usd
CY2021	orgn	Conversion Of Stockholder Convertible Notes Payable To Common Stock ConversionOfStockholderConvertibleNotesPayableToCommonStock	20493000	usd
CY2020	orgn	Conversion Of Stockholder Convertible Notes Payable To Common Stock ConversionOfStockholderConvertibleNotesPayableToCommonStock	0	usd
CY2022	orgn	Reclassification Of Redeemable Convertible Preferred Stock Warrants To Common Stock ReclassificationOfRedeemableConvertiblePreferredStockWarrantsToCommonStock	0	usd
CY2021	orgn	Reclassification Of Redeemable Convertible Preferred Stock Warrants To Common Stock ReclassificationOfRedeemableConvertiblePreferredStockWarrantsToCommonStock	54267000	usd
CY2020	orgn	Reclassification Of Redeemable Convertible Preferred Stock Warrants To Common Stock ReclassificationOfRedeemableConvertiblePreferredStockWarrantsToCommonStock	0	usd
CY2022	orgn	Reclassification Of Contingently Issued Equity To Liability ReclassificationOfContingentlyIssuedEquityToLiability	0	usd
CY2021	orgn	Reclassification Of Contingently Issued Equity To Liability ReclassificationOfContingentlyIssuedEquityToLiability	203082000	usd
CY2020	orgn	Reclassification Of Contingently Issued Equity To Liability ReclassificationOfContingentlyIssuedEquityToLiability	0	usd
CY2022	orgn	Net Assets Assumed From Business Combination NetAssetsAssumedFromBusinessCombination	0	usd
CY2021	orgn	Net Assets Assumed From Business Combination NetAssetsAssumedFromBusinessCombination	81364000	usd
CY2020	orgn	Net Assets Assumed From Business Combination NetAssetsAssumedFromBusinessCombination	0	usd
CY2022	orgn	Debt Discount Related To Derivative Liability Under Noncash Investing And Financing Activities DebtDiscountRelatedToDerivativeLiabilityUnderNoncashInvestingAndFinancingActivities	0	usd
CY2021	orgn	Debt Discount Related To Derivative Liability Under Noncash Investing And Financing Activities DebtDiscountRelatedToDerivativeLiabilityUnderNoncashInvestingAndFinancingActivities	2196000	usd
CY2020	orgn	Debt Discount Related To Derivative Liability Under Noncash Investing And Financing Activities DebtDiscountRelatedToDerivativeLiabilityUnderNoncashInvestingAndFinancingActivities	0	usd
CY2022	orgn	Business Combination Transaction Costs Accrued But Not Paid BusinessCombinationTransactionCostsAccruedButNotPaid	0	usd
CY2021	orgn	Business Combination Transaction Costs Accrued But Not Paid BusinessCombinationTransactionCostsAccruedButNotPaid	609000	usd
CY2020	orgn	Business Combination Transaction Costs Accrued But Not Paid BusinessCombinationTransactionCostsAccruedButNotPaid	0	usd
CY2022	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	1687000	usd
CY2021	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	2062000	usd
CY2020	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	0	usd
CY2022	us-gaap	Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount	1894000	usd
CY2021	us-gaap	Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount	0	usd
CY2020	us-gaap	Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount	0	usd
CY2022	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	17085000	usd
CY2021	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	0	usd
CY2020	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	0	usd
CY2022Q4	orgn	Cash Cash Equivalents Restricted Cash Restricted Cash Equivalents And Marketable Securities CashCashEquivalentsRestrictedCashRestrictedCashEquivalentsAndMarketableSecurities	323800000	usd
CY2022	us-gaap	Use Of Estimates UseOfEstimates	Use of Estimates The preparation of the consolidated financial statements in accordance with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of commitments and contingencies at the date of the financial statements as well as reported amounts of expenses during the reporting periods. Estimates made by the Company include, but are not limited to, those related to the valuation of common stock and valuation of convertible preferred stock warrants prior to the Business Combination, valuation of the earnout liability, valuation of assumed common stock warrants liability, carrying amount and useful lives of property and equipment and intangible assets, impairment assessments, marketable securities, stock-based compensation expense, probabilities of achievement of performance conditions on performance stock awards, among others. The Company bases these estimates on historical experience and on various other assumptions that it believes are reasonable under the circumstances, the results of which form the basis for making judgments about the carrying amounts of assets and liabilities that are not readily apparent from other sources. Actual results could differ materially from those estimates.
CY2022	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	Concentration of Credit Risk Financial instruments that potentially subject the Company to concentrations of credit risk are primarily cash, cash equivalents and marketable securities. The Company maintains its cash, cash equivalents, and marketable securities accounts with a financial institution where, at times, deposits exceed federal insurance limits. Management believes that the Company is not exposed to significant credit risk as the Company’s deposits are held at financial institutions that management believes to be of high credit quality. The Company has not experienced any losses on these deposits.
CY2019Q3	orgn	Escrow Deposit Fair Value EscrowDepositFairValue	1300000	usd
CY2021Q4	us-gaap	Escrow Deposit EscrowDeposit	300000	usd
CY2022Q4	us-gaap	Escrow Deposit EscrowDeposit	300000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	107858000	usd
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	46637000	usd
CY2022Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	490000	usd
CY2021Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	490000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	108348000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	47127000	usd
CY2022	orgn	Grants Received GrantsReceived	400000	usd
CY2021	orgn	Grants Received GrantsReceived	0	usd
CY2020	orgn	Grants Received GrantsReceived	200000	usd
CY2022	us-gaap	Impairment Of Intangible Assets Indefinitelived Excluding Goodwill ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill	0	usd
CY2021	us-gaap	Impairment Of Intangible Assets Indefinitelived Excluding Goodwill ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill	0	usd
CY2022	orgn	Accretion Expense For Debt Issuance Cost AccretionExpenseForDebtIssuanceCost	0	usd
CY2021	orgn	Accretion Expense For Debt Issuance Cost AccretionExpenseForDebtIssuanceCost	2200000	usd
CY2020	orgn	Accretion Expense For Debt Issuance Cost AccretionExpenseForDebtIssuanceCost	100000	usd
CY2022Q4	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	11.50
CY2022Q4	orgn	Percent Of Occurrence Of A Tender Offer Or Exchange Of Our Stockholders PercentOfOccurrenceOfATenderOfferOrExchangeOfOurStockholders	0.50
CY2022	orgn	Number Of Equity Incentive Plans NumberOfEquityIncentivePlans	3	plan
CY2022Q4	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	225210000	usd
CY2021Q2	orgn	Business Combination Reversion Recapitalization Conversion Ratio BusinessCombinationReversionRecapitalizationConversionRatio	2.11
CY2021	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	36700000	usd
CY2022	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	36700000	usd
CY2021Q2	orgn	Proceeds For Business Combination Net Of Issuance Costs Paid ProceedsForBusinessCombinationNetOfIssuanceCostsPaid	467530000	usd
CY2022Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	46000	usd
CY2022Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	9792000	usd
CY2022Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	215464000	usd
CY2021Q4	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	399170000	usd
CY2021Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	295000	usd
CY2021Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	2007000	usd
CY2021Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	397458000	usd
CY2022	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	3815900000	usd
CY2021	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	2024100000	usd
CY2020	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	0	usd
CY2022	us-gaap	Debt Securities Available For Sale Realized Gain Loss DebtSecuritiesAvailableForSaleRealizedGainLoss	-1000000	usd
CY2021	us-gaap	Debt Securities Available For Sale Realized Gain Loss DebtSecuritiesAvailableForSaleRealizedGainLoss	200000	usd
CY2020	us-gaap	Debt Securities Available For Sale Realized Gain Loss DebtSecuritiesAvailableForSaleRealizedGainLoss	0	usd
CY2022Q4	us-gaap	Debt Securities Available For Sale Unrealized Loss Position DebtSecuritiesAvailableForSaleUnrealizedLossPosition	193500000	usd
CY2021Q4	us-gaap	Debt Securities Available For Sale Unrealized Loss Position DebtSecuritiesAvailableForSaleUnrealizedLossPosition	346300000	usd
CY2021Q4	us-gaap	Debt Securities Available For Sale Allowance For Credit Loss DebtSecuritiesAvailableForSaleAllowanceForCreditLoss	0	usd
CY2022Q4	us-gaap	Debt Securities Available For Sale Allowance For Credit Loss DebtSecuritiesAvailableForSaleAllowanceForCreditLoss	0	usd
CY2022Q4	us-gaap	Available For Sale Securities Debt Maturities Within One Year Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue	104000000	usd
CY2022Q4	orgn	Debt Securities Available For Sale Fair Value Maturity Allocated And Single Maturity Date Year Two DebtSecuritiesAvailableForSaleFairValueMaturityAllocatedAndSingleMaturityDateYearTwo	48065000	usd
CY2022Q4	orgn	Debt Securities Available For Sale Fair Value Maturity Allocated And Single Maturity Date After Two Years DebtSecuritiesAvailableForSaleFairValueMaturityAllocatedAndSingleMaturityDateAfterTwoYears	63399000	usd
CY2022Q4	us-gaap	Available For Sale Securities Debt Maturities Single Maturity Date AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate	215464000	usd
CY2021Q4	us-gaap	Available For Sale Securities Debt Maturities Within One Year Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue	97459000	usd
CY2021Q4	orgn	Debt Securities Available For Sale Fair Value Maturity Allocated And Single Maturity Date Year Two DebtSecuritiesAvailableForSaleFairValueMaturityAllocatedAndSingleMaturityDateYearTwo	146197000	usd
CY2021Q4	orgn	Debt Securities Available For Sale Fair Value Maturity Allocated And Single Maturity Date After Two Years DebtSecuritiesAvailableForSaleFairValueMaturityAllocatedAndSingleMaturityDateAfterTwoYears	153802000	usd
CY2021Q4	us-gaap	Available For Sale Securities Debt Maturities Single Maturity Date AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate	397458000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	158876000	usd
CY2021Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	64725000	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	4693000	usd
CY2021Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	7540000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	154183000	usd
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	57185000	usd
CY2022	us-gaap	Depreciation Depreciation	700000	usd
CY2021	us-gaap	Depreciation Depreciation	500000	usd
CY2020	us-gaap	Depreciation Depreciation	500000	usd
CY2022Q4	us-gaap	Accumulated Capitalized Interest Costs AccumulatedCapitalizedInterestCosts	1100000	usd
CY2021Q4	us-gaap	Accumulated Capitalized Interest Costs AccumulatedCapitalizedInterestCosts	900000	usd
CY2022Q4	orgn	Accumulated Capitalized Stock Based Compensation AccumulatedCapitalizedStockBasedCompensation	1900000	usd
CY2021Q4	orgn	Accumulated Capitalized Stock Based Compensation AccumulatedCapitalizedStockBasedCompensation	900000	usd
CY2022Q4	orgn	Cumulative Translation Adjustment CumulativeTranslationAdjustment	3000000	usd
CY2021Q4	orgn	Cumulative Translation Adjustment CumulativeTranslationAdjustment	-100000	usd
CY2022Q4	us-gaap	Finite Lived Patents Gross FiniteLivedPatentsGross	404000	usd
CY2021Q4	us-gaap	Finite Lived Patents Gross FiniteLivedPatentsGross	432000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	244000	usd
CY2021Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	217000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	160000	usd
CY2021Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	215000	usd
CY2022	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	0	usd
CY2021	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	0	usd
CY2020	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	0	usd
CY2022	us-gaap	Other Income OtherIncome	0	usd
CY2021	us-gaap	Other Income OtherIncome	500000	usd
CY2020	us-gaap	Other Income OtherIncome	600000	usd
CY2016Q4	orgn	Proceeds From Collaborative Agreement ProceedsFromCollaborativeAgreement	500000	usd
CY2018Q3	us-gaap	Research And Development Expense Excluding Acquired In Process Cost ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost	1500000	usd
CY2022	orgn	Number Of Offtake Supply Agreements NumberOfOfftakeSupplyAgreements	8	agreement
CY2022	orgn	Number Of Offtake Supply Agreements With Same Customer NumberOfOfftakeSupplyAgreementsWithSameCustomer	2	agreement
CY2022	orgn	Number Of Offtake Supply Agreements NumberOfOfftakeSupplyAgreements	8	agreement
CY2022	orgn	Number Of Customers With Offtake Supply Agreements Containing Option To Terminate Agreement NumberOfCustomersWithOfftakeSupplyAgreementsContainingOptionToTerminateAgreement	2	customer1
CY2022	orgn	Offtake Supply Agreement Initial Term OfftakeSupplyAgreementInitialTerm	P10Y
CY2022	orgn	Offtake Supply Agreement Amendment Number Of Fixed Repayments OfftakeSupplyAgreementAmendmentNumberOfFixedRepayments	3	repayment
CY2022	orgn	Offtake Supply Agreement Amendment To Repayment Period OfftakeSupplyAgreementAmendmentToRepaymentPeriod	P3M
CY2022	us-gaap	Loss Contingency Damages Awarded Value LossContingencyDamagesAwardedValue	200000	usd
CY2022Q4	us-gaap	Deposit Liabilities Accrued Interest DepositLiabilitiesAccruedInterest	5400000	usd
CY2021Q4	us-gaap	Deposit Liabilities Accrued Interest DepositLiabilitiesAccruedInterest	5200000	usd
CY2016Q4	us-gaap	Other Long Term Debt OtherLongTermDebt	5000000	usd
CY2022	orgn	Earnout Shares Post Triggering Event Period EarnoutSharesPostTriggeringEventPeriod	P10D
CY2022Q4	orgn	Common Stock Earnout Shares CommonStockEarnoutShares	25000000	shares
CY2022Q4	us-gaap	Common Stock Other Shares Outstanding CommonStockOtherSharesOutstanding	4500000	shares
CY2019Q2	orgn	Lesser Eligible Costs Percentage LesserEligibleCostsPercentage	0.1848
CY2019Q2	orgn	Lesser Eligible Costs LesserEligibleCosts	23000000	cad
CY2019Q2	orgn	Funding Repayment Period FundingRepaymentPeriod	P15Y
CY2019Q2	orgn	Development Program Liability Maximum Repayment Ratio Compared To Actual Funding Received DevelopmentProgramLiabilityMaximumRepaymentRatioComparedToActualFundingReceived	1.25
CY2021Q2	orgn	Development Program Liability Funding Reduction Percentage DevelopmentProgramLiabilityFundingReductionPercentage	0.50
CY2019Q2	orgn	Minimum Costs Of Commercial Plants MinimumCostsOfCommercialPlants	500000000	cad
CY2019Q2	orgn	Commercial Plants Constructed And Operational Period CommercialPlantsConstructedAndOperationalPeriod	P30M
CY2022Q4	orgn	Funding Liability FundingLiability	7200000	usd
CY2021Q4	orgn	Funding Liability FundingLiability	6800000	usd
CY2022Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	35476627	shares
CY2021Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	35476627	shares
CY2022Q4	orgn	Assumed Common Stock Warrants Liability Noncurrent AssumedCommonStockWarrantsLiabilityNoncurrent	30900000	usd
CY2021Q4	orgn	Assumed Common Stock Warrants Liability Noncurrent AssumedCommonStockWarrantsLiabilityNoncurrent	52900000	usd
CY2022	orgn	Change In Fair Value Of Gain Loss Assumed Warrants ChangeInFairValueOfGainLossAssumedWarrants	22000000	usd
CY2021	orgn	Change In Fair Value Of Gain Loss Assumed Warrants ChangeInFairValueOfGainLossAssumedWarrants	30500000	usd
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2021Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2022	us-gaap	Common Stock Voting Rights CommonStockVotingRights	one
CY2022Q4	orgn	Sponsor Vesting Shares Outstanding SponsorVestingSharesOutstanding	4500000	shares
CY2021Q4	orgn	Sponsor Vesting Shares Outstanding SponsorVestingSharesOutstanding	4500000	shares
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Expiration Period SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod	P10Y
CY2022Q4	us-gaap	Common Stock Capital Shares Reserved For Future Issuance CommonStockCapitalSharesReservedForFutureIssuance	27846011	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant	15728837	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant	11285104	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	3588523	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	4130184	shares
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	8500000	usd
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	300000	usd
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue	28700000	usd
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue	49300000	usd
CY2022Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	4700000	usd
CY2021Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	6600000	usd
CY2022Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	27000000	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	81269000	usd
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	43645000	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	-2700000	usd
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	-1555000	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	78569000	usd
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	42090000	usd
CY2022	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	0	usd
CY2021	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	0	usd
CY2022	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	3000	usd
CY2021	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	3000	usd
CY2022	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	0	usd
CY2021	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	0	usd
CY2022	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	3000	usd
CY2021	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	3000	usd
CY2022	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	0	usd
CY2021	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	0	usd
CY2022	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	0	usd
CY2021	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	0	usd
CY2022	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	0	usd
CY2021	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	0	usd
CY2022	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	0	usd
CY2021	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	0	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	3000	usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	3000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	27210000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	24899000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Unrealized Losses On Availablefor Sale Securities Gross DeferredTaxAssetsUnrealizedLossesOnAvailableforSaleSecuritiesGross	2064000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Unrealized Losses On Availablefor Sale Securities Gross DeferredTaxAssetsUnrealizedLossesOnAvailableforSaleSecuritiesGross	390000	usd
CY2022Q4	orgn	Deferred Tax Assets Leasing Arrangments DeferredTaxAssetsLeasingArrangments	532000	usd
CY2021Q4	orgn	Deferred Tax Assets Leasing Arrangments DeferredTaxAssetsLeasingArrangments	341000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	1580000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	230000	usd
CY2022Q4	orgn	Deferred Tax Assets Property Plant And Equipment And Intangibles DeferredTaxAssetsPropertyPlantAndEquipmentAndIntangibles	25000	usd
CY2021Q4	orgn	Deferred Tax Assets Property Plant And Equipment And Intangibles DeferredTaxAssetsPropertyPlantAndEquipmentAndIntangibles	89000	usd
CY2022Q4	orgn	Deferred Tax Assets Capitalized Research And Development DeferredTaxAssetsCapitalizedResearchAndDevelopment	1929000	usd
CY2021Q4	orgn	Deferred Tax Assets Capitalized Research And Development DeferredTaxAssetsCapitalizedResearchAndDevelopment	0	usd
CY2022Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	33340000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	25949000	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities Leasing Arrangements DeferredTaxLiabilitiesLeasingArrangements	515000	usd
CY2021	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	-0.013
CY2021Q4	us-gaap	Deferred Tax Liabilities Leasing Arrangements DeferredTaxLiabilitiesLeasingArrangements	344000	usd
CY2022Q4	orgn	Deferred Tax Liabilities Property Plant And Equipment And Intangibles DeferredTaxLiabilitiesPropertyPlantAndEquipmentAndIntangibles	479000	usd
CY2021Q4	orgn	Deferred Tax Liabilities Property Plant And Equipment And Intangibles DeferredTaxLiabilitiesPropertyPlantAndEquipmentAndIntangibles	0	usd
CY2022Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	994000	usd
CY2021Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	344000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	32346000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	25605000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	0	usd
CY2021Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	0	usd
CY2022	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	6700000	usd
CY2021	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	6900000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards Domestic DeferredTaxAssetsOperatingLossCarryforwardsDomestic	110200000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards Foreign DeferredTaxAssetsOperatingLossCarryforwardsForeign	8500000	usd
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210
CY2021	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210
CY2022	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.011
CY2022	orgn	Effective Income Tax Rate Reconciliation Warrants Bcf And Other Equity Items EffectiveIncomeTaxRateReconciliationWarrantsBCFAndOtherEquityItems	-22559000	usd
CY2022	orgn	Effective Income Tax Rate Reconciliation Warrants Bcf And Other Equity Items Percent EffectiveIncomeTaxRateReconciliationWarrantsBCFAndOtherEquityItemsPercent	-0.287
CY2021	orgn	Effective Income Tax Rate Reconciliation Warrants Bcf And Other Equity Items Percent EffectiveIncomeTaxRateReconciliationWarrantsBCFAndOtherEquityItemsPercent	-0.333
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	0.064
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	0.156
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0.007
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	-0.002
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential	-0.002
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential	-0.002
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost	-0.003
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost	-0.016
CY2022	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0
CY2021	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0
CY2022	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	16500000	usd
CY2021	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	8833000	usd
CY2022	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	875000	usd
CY2021	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-563000	usd
CY2021	orgn	Effective Income Tax Rate Reconciliation Warrants Bcf And Other Equity Items EffectiveIncomeTaxRateReconciliationWarrantsBCFAndOtherEquityItems	-14002000	usd
CY2022	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	5040000	usd
CY2021	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	6552000	usd
CY2022	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	502000	usd
CY2021	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	-72000	usd
CY2022	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	-148000	usd
CY2021	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	-85000	usd
CY2022	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	-207000	usd
CY2021	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	-660000	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	3000	usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	3000	usd
CY2022Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	usd
CY2021Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	usd
CY2021	orgn	Lessee Operating Lease Number Of Amended Leases LesseeOperatingLeaseNumberOfAmendedLeases	2	lease
CY2020	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	300000	usd
CY2022	us-gaap	Operating Lease Cost OperatingLeaseCost	671000	usd
CY2021	us-gaap	Operating Lease Cost OperatingLeaseCost	324000	usd
CY2022	us-gaap	Variable Lease Cost VariableLeaseCost	107000	usd
CY2021	us-gaap	Variable Lease Cost VariableLeaseCost	68000	usd
CY2022	us-gaap	Lease Cost LeaseCost	778000	usd
CY2021	us-gaap	Lease Cost LeaseCost	392000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	2779000	usd
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1782000	usd
CY2022Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P5Y3M10D
CY2021Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P7Y5M8D
CY2022Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.034
CY2021Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.028
CY2022	orgn	Operating Cash Flows From Operating Leases OperatingCashFlowsFromOperatingLeases	572000	usd
CY2021	orgn	Operating Cash Flows From Operating Leases OperatingCashFlowsFromOperatingLeases	271000	usd
CY2022	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	1687000	usd
CY2021	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	2062000	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	703000	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	563000	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	465000	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	479000	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	493000	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	422000	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	3125000	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	257000	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	619000	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	2249000	usd
CY2020	orgn	Royalty Payment For License Agreement RoyaltyPaymentForLicenseAgreement	0	usd
CY2022	orgn	Royalty Payment For License Agreement RoyaltyPaymentForLicenseAgreement	0	usd
CY2021	orgn	Royalty Payment For License Agreement RoyaltyPaymentForLicenseAgreement	0	usd
CY2022	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	78569000	usd
CY2021	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	42090000	usd
CY2020	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-30302000	usd
CY2022	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	78569000	usd
CY2021	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	42090000	usd
CY2020	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-30302000	usd
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	137563877	shares
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	101221781	shares
CY2020	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	62544933	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	142146767	shares
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	106237754	shares
CY2020	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	62544933	shares
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.57
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.42
CY2020	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.48
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.55
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.40
CY2020	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.48
CY2022	us-gaap	Weighted Average Number Of Shares Common Stock Subject To Repurchase Or Cancellation WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation	4500000	shares
CY2021	us-gaap	Weighted Average Number Of Shares Common Stock Subject To Repurchase Or Cancellation WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation	2342466	shares
CY2022Q4	us-gaap	Common Stock Shares Held In Employee Trust Shares CommonStockSharesHeldInEmployeeTrustShares	1481531	shares
CY2021Q4	us-gaap	Common Stock Shares Held In Employee Trust Shares CommonStockSharesHeldInEmployeeTrustShares	1481531	shares
CY2020Q4	us-gaap	Common Stock Shares Held In Employee Trust Shares CommonStockSharesHeldInEmployeeTrustShares	0	shares
CY2022Q4	orgn	Common Stock Performance Shares CommonStockPerformanceShares	2218925	shares
CY2021Q4	orgn	Common Stock Performance Shares CommonStockPerformanceShares	2137500	shares
CY2020Q4	orgn	Common Stock Performance Shares CommonStockPerformanceShares	0	shares
CY2022Q4	orgn	Common Stock Earnout Shares CommonStockEarnoutShares	25000000	shares
CY2021Q4	orgn	Common Stock Earnout Shares CommonStockEarnoutShares	25000000	shares
CY2020Q4	orgn	Common Stock Earnout Shares CommonStockEarnoutShares	0	shares
CY2022Q4	us-gaap	Common Stock Other Shares Outstanding CommonStockOtherSharesOutstanding	4500000	shares
CY2021Q4	us-gaap	Common Stock Other Shares Outstanding CommonStockOtherSharesOutstanding	4500000	shares
CY2020Q4	us-gaap	Common Stock Other Shares Outstanding CommonStockOtherSharesOutstanding	0	shares

Files In Submission

Name	View Source	Status
0001802457-23-000018-index-headers.html	Edgar Link	pending
0001802457-23-000018-index.html	Edgar Link	pending
0001802457-23-000018.txt	Edgar Link	pending
0001802457-23-000018-xbrl.zip	Edgar Link	pending
danone_originxotaorigin2.htm	Edgar Link	pending
danone_originxotaorigin2001.jpg	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
orgn-20221231.htm	Edgar Link	pending
orgn-20221231.xsd	Edgar Link	pending
orgn-20221231xexx231.htm	Edgar Link	pending
orgn-20221231xexx311.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
orgn-20221231xexx312.htm	Edgar Link	pending
orgn-20221231xexx313.htm	Edgar Link	pending
orgn-20221231xexx321.htm	Edgar Link	pending
orgn-20221231_g1.jpg	Edgar Link	pending
orgn-20221231_g2.jpg	Edgar Link	pending
orgn-20221231_g3.jpg	Edgar Link	pending
orgn-20221231_g4.jpg	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
orgn-20221231_def.xml	Edgar Link	unprocessable
orgn-20221231_pre.xml	Edgar Link	unprocessable
orgn-20221231_lab.xml	Edgar Link	unprocessable
orgn-20221231_htm.xml	Edgar Link	completed
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
orgn-20221231_cal.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$ORGN
Origin Materials, Inc. Stock $orgn

2023 Q1 Form 10-K Financial Statement

#000180245723000018 Filed on February 23, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ORGN Origin Materials, Inc. Stock $orgn

2023 Q1 Form 10-K Financial Statement

#000180245723000018 Filed on February 23, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ORGN
Origin Materials, Inc. Stock $orgn